INTRODUCTION {#s1}
============

Chronic obstructive pulmonary disease (COPD) is an inflammatory disease characterized by an exacerbated inflammatory response and/or alveolar abnormalities usually caused by constant exposure to noxious particles and gases, most commonly due to cigarette smoke (CS) ([@BIO040808C5]; [@BIO040808C8]).

Macrophages play a pivotal role in the clearance of exogenous particles, in the defense against pathogens of the respiratory tract and are recognized as important mediators of the inflammatory response in COPD. An increased number of macrophages in lung and sputum samples have been found in COPD patients ([@BIO040808C7]) and the degree of the disease has been shown to be associated with the extent of the increase in these cells ([@BIO040808C4]; [@BIO040808C10]).

Depending on the microenvironment stimuli, macrophages can be polarized into M1- or M2-like phenotypes with different functional capacities ([@BIO040808C17]). M1 polarization occurs in the presence of interferon (IFN)-γ or by exposure to pathogen components ([@BIO040808C6]; [@BIO040808C13]) during the Th1-mediated immune response, exerting cytotoxic and antitumoral functions.

In contrast, M2 polarization is induced by exposure to Th2 cytokines such as interleukin (IL)-4 and IL-13 (M2a polarization) or by combined exposure to immune complexes and toll-like receptor (TLR) or IL-1R agonists (M2b polarization), showing immunoregulatory functions. In the presence of IL-10 (M2c polarization) macrophages are able to suppress immune responses and stimulate tissue remodeling ([@BIO040808C13]).

Animal models are widely used to provide better mechanistic insights into the pathogenesis of COPD ([@BIO040808C20]) however, it is important to understand the advantages and disadvantages of each model.

The CS and elastase-induced models are the most commonly used models since they are physiologically similar to the human disease. However, there are important differences between both models in terms of the inflammatory profile, the level of alveolar destruction and the required time to disease development ([@BIO040808C21]).

Exposure to CS is considered the best experimental model at mimicking the pathogenesis of the human disease, since smoking is still considered the main cause of the development of COPD. However, a disadvantage of this model is that although it requires a long time of exposure, the resulting alveolar enlargement is mild in comparison with that resulting from animal models of protease instillation ([@BIO040808C21]; [@BIO040808C11]; [@BIO040808C12]).

In contrast, the elastase-induced model, depending on the doses, induces quicker and greater alveolar destruction than that in the CS model ([@BIO040808C3]). However, a major disadvantage of this model is that it does not trigger all the physiological events observed in the CS models ([@BIO040808C21]).

Considering the importance of macrophages in the development of COPD ([@BIO040808C1]) and bearing in mind that there are differences in the pathophysiological mechanisms between both mostly used experimental models, we aimed, in this study, to evaluate how the differences in microenvironment stimuli could interfere with macrophage polarization, by comparing the elastase and the CS-induced models.

RESULTS {#s2}
=======

Lung morphometry {#s2a}
----------------

The Lm revealed an increase in the two experimental models proposed, demonstrating the increase in the distal airspaces ([Figs 1](#BIO040808F1){ref-type="fig"},[2](#BIO040808F2){ref-type="fig"}). Fig. 1.**Lm (A,B) values measured in experimental groups.** (A) \**P*=0.009, (B) \**P*=0.001. Results were expressed as the mean±s.e. Saline *n*=10; PPE *n*=8; control *n*=8; CS *n*=9. Fig. 2.**Photomicrographs of Lm in the distal airspaces of saline, PPE, control and CS groups.** 200× magnification, scale bars: 100 μm.

Immunohistochemistry for total macrophages {#s2b}
------------------------------------------

The density of the MAC-2+ cells was increased in the PPE and CS groups compared to their respective controls ([Figs 3](#BIO040808F3){ref-type="fig"},[4](#BIO040808F4){ref-type="fig"}). Fig. 3.**The density of positive cells for MAC-2 (A,B).** (A) \**P*=0.001, (B) \**P*=0.001 compared to their respective controls. Values are expressed as the mean±s.e. Saline *n*=11; PPE *n*=10; control *n*=11; CS *n*=9. Fig. 4.**Photomicrographs of positive cells for MAC-2 and their respective negative controls in lung parenchyma in saline, PPE, control and CS groups.** The arrows show the MAC-2+ cells in lung parenchyma. 400× magnification, scale bars: 50 μm.

Immunohistochemistry for M1-like macrophages markers {#s2c}
----------------------------------------------------

The density of the positive cells involved in the differentiation of the M1-like macrophages demonstrated an increase in IFN-γ and TNF-α in the PPE and CS groups compared to their respective controls ([Figs 5](#BIO040808F5){ref-type="fig"},[7](#BIO040808F7){ref-type="fig"}). Fig. 5.**The density of positive cells for IFN- γ (A,B) and TNF-α (C,D), M1-like macrophages markers.** (A) \**P*=0.004, (B) \**P*=0.001, (C) \**P*=0.037, (D) \**P*=0.001, compared to their respective controls. Values are expressed as the mean±s.e. IFN-γ: saline *n*=8; PPE *n*=10; control *n*=9; CS *n*=9. TNF-α: saline *n*=8; PPE *n*=10; control *n*=9; CS *n*=9.

Immunohistochemistry for M2-like macrophages markers {#s2d}
----------------------------------------------------

The density of TGF-β+ cells, a cytokine which characterizes M2-like macrophage, was increased in PPE and CS induced inflammation, while IL-10+ cells density was decreased in the PPE group compared to the saline group and increased in the CS group compared to the respective control ([Figs 6](#BIO040808F6){ref-type="fig"},[7](#BIO040808F7){ref-type="fig"}). Fig. 6.**The density of positive cells for TGF-β (A,B) and IL-10 (C,D), M2-like macrophages markers.** (A) \**P*=0.001, (B) \**P*=0.001, (C) \**P*=0.041, (D) \**P*=0.029, compared to their respective controls. Values are expressed as the mean±s.e. TGF-β: saline *n*=9; PPE *n*=8; control *n*=8; CS *n*=9. IL-10: saline *n*=8; PPE *n*=8; control *n*=7; CS *n*=7. Fig. 7.**Photomicrographs of positive cells for IFN-γ, TNF-α, TGF-β and IL-10 in lung parenchyma in saline, PPE, control and CS groups.** The arrows show IFN-γ+, TNF-α+, TGF-β+ and IL-10+ cells in lung parenchyma. 400× magnification, scale bars: 50 μm.

Cytokine analysis detected by ELISA {#s2e}
-----------------------------------

There was no expression of IL-12 and IFN-γ M1-like macrophage markers; however, we observed a decrease in the expression of IL-4 ([Fig. 9](#BIO040808F9){ref-type="fig"}A), IL-10 ([Fig. 9](#BIO040808F9){ref-type="fig"}C) and IL-13 ([Fig. 9](#BIO040808F9){ref-type="fig"}E), markers of M2-like macrophage, in the PPE group compared to the saline group. We found an increased expression of IL-10 ([Fig. 9](#BIO040808F9){ref-type="fig"}D) only in the CS group compared to the control group ([Fig. 9](#BIO040808F9){ref-type="fig"}). Fig. 8.**Photomicrographs of negative control images for IFN-γ, TNF-α, TGF-β and IL-10 in lung parenchyma in saline, PPE, control and CS groups.** 400× magnification, scale bars: 50 μm. Fig. 9.**Protein quantification of IL-4 (A,B), IL-10 (C,D), and IL-13 (E,F) by ELISA.** (A) \**P*=0.016, (C) \**P*=0.046, (D) \**P*=0.028, (E) \**P*=0.007, compared to their respective controls. Values are expressed as the mean±s.e. IL-4: saline *n*=10; PPE *n*=9; control *n*=8; CS *n*=6. IL-10: saline *n*=7; PPE *n*=8; control *n*=6; CS *n*=6. IL-13: saline *n*=6; PPE *n*=9; control *n*=6; CS *n*=7.

RT-qPCR -- markers of M1-like macrophages {#s2f}
-----------------------------------------

Gene expression in M1-like macrophages was expressed in arbitrary units. We found increased *Cxcl9* expression in the PPE group compared to respective control ([Fig. 10](#BIO040808F10){ref-type="fig"}A). However, *Cxcl10* gene expression was increased in both the PPE and CS groups compared to their respective controls ([Fig. 10](#BIO040808F10){ref-type="fig"}B). We observed decreased *Il-12b* gene expression in lungs from the CS group compared to the control group ([Fig. 10](#BIO040808F10){ref-type="fig"}E). There was no statistically significant difference in gene expression of *Irf5* ([Fig. 10](#BIO040808F10){ref-type="fig"}C) and *iNos* ([Fig. 10](#BIO040808F10){ref-type="fig"}D) between the different experimental groups ([Fig. 10](#BIO040808F10){ref-type="fig"}). Fig. 10.**Gene expression for *Cxcl9* (A,B), *Cxcl10* (C,D), Il-12b (E,F).** (A) \**P*=0.004, (B) \**P*=0.017, compared to their respective controls. (C) \**P*=0.001, (D) \**P*=0.036, compared to their respective controls. (F) \**P*=0.026, compared to the control group. We did not observe any significant results following *iNos* (G,H) and *Irf-5* (I,J) analysis. Values are expressed as the mean±s.e. CXCL9: saline *n*=14; PPE *n*=13; control *n*=11; CS *n*=13. CXCL10: saline *n*=14; PPE *n*=14; control *n*=11; CS *n*=16. IL-12b: saline *n*=13; PPE *n*=13; control *n*=10; CS *n*=11. iNOS: saline *n*=7; PPE *n*=4; control *n*=4; CS *n*=3. Irf5: saline *n*=14; PPE *n*=15; control *n*=12; CS *n*=17.

RT-qPCR -- markers of M2-like macrophages {#s2g}
-----------------------------------------

The evaluation of gene expression for M2-like macrophages markers revealed a decrease for the expression of *Arg1* ([Fig. 11](#BIO040808F11){ref-type="fig"}A) and *Fizz1* ([Fig. 11](#BIO040808F11){ref-type="fig"}D) in the PPE group compared to the saline group. There was no significant difference between experimental groups for *Ym1* and *Irf4* gene expression ([Fig. 11](#BIO040808F11){ref-type="fig"}B,C). Fig. 11.**Gene expression for *Arg1* (A,B), *Fizz1* (C,D).** (A)\**P*=0.005 compared to the saline group. (C) \**P*=0.001 compared to the saline group. No differences in *Ym1* and (E,F) *Irf4* (G,H) gene expression were detected. Values are expressed as the mean±s.e. Arg1: saline *n*=14; PPE *n*=15; control *n*=12; CS *n*=17. Fizz1: saline *n*=13; PPE *n*=14; control *n*=12; CS *n*=16. Ym1: saline *n*=13; PPE *n*=14; control *n*=9; CS *n*=16. Irf4: saline *n*=14; PPE *n*=14; control *n*=10; CS *n*=14.

DISCUSSION {#s3}
==========

Our results showed differences in microenvironmental stimuli due to gene expression and due to the release of chemokine related to M1- and M2-like macrophage phenotypes in the CS and PPE-induced models. Whereas the CS-induced model showed M1 and M2-related genes and chemokines, the PPE-induced model showed a downregulation of M2- and an increase in M1-related genes and chemokines ([Table 1](#BIO040808TB1){ref-type="table"}). Table 1.**Significant results of the PPE and CS groups compared to their respective controls**

Considering the structural changes in the lung parenchyma, we observed an alveolar enlargement in both models. However, a higher mean linear intercept was observed in the PPE model, reinforcing previous findings that describe greater alveolar destruction by proteases than that in the CS-induced models ([@BIO040808C21]; [@BIO040808C11]). There were no significant differences, despite the age difference, when we compared the control group (saline, 28 day; control, 3 month) at the end of their respective exposures.

After 28 days of PPE instillation, we observed a decrease in the majority of M2-related genes and chemokines such as IL-4, IL-10, IL-13, *Arg*1, *Fizz1*. On the other hand, we found a higher density of TNF-α+, IFN-γ+ cells and increased gene expression of *Cxcl9* and *Cxcl10*, resulting in stimuli that induce M1-like macrophage polarizations.

Analysis of the interleukins in the CS model revealed that after 3 months of exposure, there was a decreased expression of *IL-12b*, IL-4, IL-13, *Fizz1* and *Arg1*, while we noted an increase in IL-10 expression, suggesting a polarization towards M2-like macrophage polarization.

[@BIO040808C14] described different subtypes of M2 phenotypes (M2a, M2b and M2c) with different functions. In the CS group, we observed an increase in IL-10 by immunohistochemistry and ELISA with a concomitant decrease in *IL-12b* gene expression associated with an increase in TNF-α+ cells in the parenchyma, suggesting the presence of an M2b polarized phenotype, which exert immunoregulatory functions and drive Th2 responses. Additionally, we detected an increase in TGF-β+ cells and IL-10 expression, which are characteristic of M2c-like macrophage and associated with immune response suppression and tissue remodeling.

In addition, CS exposure also induced a significant increase in chemokines and gene expression related to M1-like macrophage polarizations such as TNF-α, IFN-γ and *Cxcl9*.

Although the CS- and PPE-induced models are basically different, both models showed proteolysis and pulmonary inflammation and an increase in macrophages in the respiratory tract ([@BIO040808C21]).

There is a large body of evidence attesting the importance of macrophages in the progression of the inflammatory response in COPD patients. Indeed, there is a positive correlation between COPD severity and the increase in macrophages in the airways ([@BIO040808C19]).

We showed, in both experimental models, an increase in the density of macrophages in the lung parenchyma and an increase in the inflammatory mediators that induce M1 polarization. However, M2-like related genes and chemokines were observed only in animals that were chronically exposed to CS.

Until now, there have been few studies describing macrophage polarization in COPD patients. [@BIO040808C17] showed that during the development of COPD, a suppression of host defenses and a decrease in M1 polarization occur, along with a concomitant increase in immunosuppressive factors such as IL-10 and TGF-β related to M2-like macrophage polarizations.

On the other hand, [@BIO040808C9] described a mixed phenotype in the bronchoalveolar lavage fluid from COPD patients compared to healthy smokers. They also detected a defective activity to phagocyte apoptotic cells.

Macrophages display remarkable plasticity, changing their physiology in response to environmental stimuli ([@BIO040808C9]). During the development of COPD, both M1- and M2-like macrophage polarizations are present ([@BIO040808C16]).

The increased M2 phenotype observed in COPD patients may reflect a deficiency in the control of the inflammatory process mediated by the phagocytosis of apoptotic cells. A deficiency in the removal of apoptotic cells improves the inflammatory process and the progression of this disease ([@BIO040808C18]).

Our results showed that the consequences of the CS-induced model were similar to those previously described in COPD patients, with both M1- and M2-related genes and chemokines being increased. This response is probably due to the chronic exposure to CS compared to the PPE-induced model that required a single elastase instillation.

It is important to note that, due to the anatomical and physiological differences between humans and other species, there is no ideal animal model that is able to mimic all features observed in human diseases ([@BIO040808C17]; [@BIO040808C18]). Therefore, it is important to better characterize the physiological features of each animal model before choosing one for further investigations.

Considering our results, exposure to CS in rodents may be able to better reproduce some features of the innate immune response that have already been described in COPD patients compared to those in the PPE-induced model. Chronic exposure to CS resulted in an inflammatory process induced by an environmental stimulus related to the M1-like and M2-like polarized phenotypes.

MATERIALS AND METHODS {#s4}
=====================

Animals {#s4a}
-------

This study was approved by the Human and Animal Research Ethics Committee of the University of São Paulo School of Medicine under protocol number 136/2015 (São Paulo, Brazil). We used six- to eight-week-old male C57BL/6 mice (weighing 20--25 g) all animals received human care in compliance with the US National Institutes of Health Guide for the Care and Use of Laboratory Animals (NIH Publication no. 85--23, revised in 1996).

Induction of emphysema {#s4b}
----------------------

### Porcine pancreatic elastase (PPE)-induced model {#s4b1}

Animals were anesthetized with a combination of xylazine and ketamine (5 mg/kg and 40 mg/kg, respectively) to allow for intranasal instillation of 50 µl of type I PPE (E1250; Sigma-Aldrich, St. Louis, MO, USA) at a dose of 0.667 IU. The saline group received 50 µl of saline (0.9%) by intranasal instillation.

### CS-induced model {#s4b2}

We used a plastic box (28 l) with two inlets for filtered air and CS ([@BIO040808C2]). A flow meter was regulated using a Venturi system connected to a lit cigarette, allowing for suction of the CS into the box and maintaining the airflow at 2 l/min. A flow rate was set to produce carbon monoxide levels ranging from 250--350 ppm. We used approximately 12 (±1) commercially filtered cigarettes per day (Derby, Souza Cruz, Brazil; 0.8 mg of nicotine, 10 mg of tar and 10 mg of carbon monoxide per cigarette) with a total particulate matter concentration of 354.8±50.3 μg/m^3^/day. The exposures to CS were performed for 30 min/exposure, two times/day, 5 days/week for a period of 12 weeks. The control group were exposed to filtered air ([@BIO040808C19]).

Experimental groups {#s4c}
-------------------

The animals were divided into four different experimental groups: saline group; animals received intranasal instillation of saline (0.9%). PPE group; animals received intranasal instillation of PPE. Control group; animals were exposed to filtered air. CS group; animals were exposed to CS.

Lung preparation {#s4d}
----------------

To remove the lungs, animals were euthanized under anesthesia (Thiopental 50 mg/kg). Lungs were infused with formalin through the trachea at a constant pressure of 20 cmH~2~O for 24 h and were embedded in paraffin and cut into 5 µm coronal sections for morphometry evaluation.

Morphometry {#s4e}
-----------

For conventional morphometry, tissue samples were stained with H&E to perform the mean linear intercept (Lm) measurements. Lm was obtained by counting the number of times that the lines of the reticulum intercepted the alveolar walls using following equation: Lm=Ltotal/NI ([@BIO040808C16]). We performed the Lm analysis in the distal areas of the parenchyma (peripheral airspaces).

Immunohistochemistry {#s4f}
--------------------

To perform immunohistochemistry, tissue sections were deparaffinized and hydrated. After blocking endogenous peroxidase activity, antigen retrieval was obtained under a high temperature using citrate buffer (pH=6.0). The primary antibodies used were: a rat monoclonal anti-MAC-2 (1:25.000, Cedarlane, Ontario, Canada), a rat monoclonal anti-IFN-γ (1:1000, Santa Cruz Biotechnology, USA), a rat monoclonal anti-TNF-α, (1:15,000, Santa Cruz Biotechnology), a goat polyclonal anti-IL-10 (1:50, Santa Cruz Biotechnology), a rabbit polyclonal anti-TGF-β (1:400, Santa Cruz Biotechnology). The following Vectastain ABC Kit (Vector Laboratories, Burlingame, USA) was used in conjunction with a species-specific secondary antibody (Nichirei Biosciences, Tokyo, Japan), and the sections were stained using the chromogen diaminobenzidine (Sigma-Aldrich). The sections were counterstained with Harris Hematoxylin (Merck, Darmstadt, Germany). For negative controls ([Fig. 8](#BIO040808F8){ref-type="fig"}) the primary antibody was omitted from the procedure ([@BIO040808C19]) and bovine serum albumin was used instead in tissue samples.

The density of MAC-2 +, IFN-γ+, TNF-α+, IL-10+, and TGF-β+ cells in lung parenchyma were quantified. For this, we used the same reticule of 100 points and 50 straight lines with a known area (62.500 μm^2^) under 400× magnification. The area of the alveolar tissue in each field was calculated according to the number of points that intercepted the alveolar septa and determined with the following equation: positive cell density=number of positive cells/number of points that were parenchymatic, the result was expressed as cells/μm^2^ ([@BIO040808C15]).

Cytokine analysis {#s4g}
-----------------

Levels of IFN-γ, IL-12 (cytokines characteristic of M1-like macrophages); IL-4; IL-10 and IL-13 (cytokines characteristic of M2-like macrophages) were determined by ELISA (OptEIA, BD Pharmingen, Oxford, UK) in bronchoalveolar lavage using microplates (Costar, Cambridge, MA, USA) for each cytokine sensitized with specific monoclonal antibodies. After washing and distribution of the samples, specific antibodies conjugated to biotin were added to the different cytokines. For development of the bond, a developer solution containing streptavidin-peroxidase, substrate and a chromogen enzyme conjugate were added. The reaction was read at 450 nm in a M2 spectrophotometer (Spectramax L, Molecules Devices, CA, USA). Sample concentrations were calculated using the standard curves obtained with the recombinant cytokines and the result was expressed per pg/ml.

Real time PCR {#s4h}
-------------

RNA extraction, reverse transcription and quantitative real-time PCR (qRT-PCR) were performed in lung homogenate. Total RNA from 3T3-L1 cell lysates was extracted using TRIzol (Invitrogen Life Technologies, CA, USA), analyzed for quality on agarose gel and read using absorbance ratios of 260/280 nm and 260/230 nm, and reverse transcribed to cDNA using the SuperScript III cDNA kit (Invitrogen Life Technologies). Gene expression was evaluated by qRT-PCR using a Rotor Gene (Qiagen, Roermond, Netherlands) and SYBR Green as the fluorescent dye (Qiagen) with GAPDH as the housekeeping gene. The reaction conditions were as follows: 95°C for 5 min, then 40 cycles of 95°C for 5 s and 60°C for 10 s. PCR products were run on agarose gels to confirm the size of the fragment and specificity of amplification. the primers used were as follows: *Irf-5* (5′-3′ sense: AATACCCCACCACCTTTTGA; 5′-3′ antisense: TTGAGATCCGGGTTTGAGAT); *Irf-4* (5′-3′ sense: CAAAGCACAGAGTCACCTGG; 5′-3′ antisense: TGCAAGCTCTTTGACACACA); *Fizz-1* (5′-3′ sense: TCCCAGTGAATACTGATGAGA; 5′-3′ antisense: CCACTCTGGATCTCCCAAGA); *Ym-1* (5′-3′ sense: GGGCATACCTTTATCCTGAG; 5′-3′ antisense: CCACTGAAGTCATCCATGT); *Cxcl-9* (5′-3′ sense: TGCACGATGCTCCTGCA; 5′-3′ antisense: AGGTCTTTGAGGGATTTGTAGTGG); *Cxcl-10* (5′-3′ sense: GACGGTCCGCTGCAACTG; 5′-3′ antisense: GCTTCCCTATGGCCCTCATT); *Il-12b* (5′-3′ sense: CGCAAGAAAGAAAAGATGAAGGAG; 5′-3′ antisense: TTGCATTGGACTTCGGTAGATG); *Arg-1* (5′-3′ sense: GCACTCATGGAAGTACACGAGGAC; 5′-3′ antisense: CCAACCCAGTGATCTTGACTGA); *iNos* (5′-3′ sense: ACCCGTCCACAGTATGTGAGGA; 5′-3′ antisense: GACCCCAAGCAAGACTTGGACT) and *Gapdh* (5′-3′ sense: CCACCACCCTGTTGCTGTAG; 5′-3′ antisense: CTTGGGCTACACTGAGGACC).

Statistical analysis {#s4i}
--------------------

Statistical analysis was performed using the SigmaStat program (Systat Software, San Jose, CA, USA; version 11.0). A *t*-test or Mann--Whitney test was used depending on the normality of the data. The results are expressed as the means±s.e. and *P*-values \<0.05 were considered as statistically significant.
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